Sign Up
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Phio Pharmaceuticals to present corporate and clinical update at Life Sciences Future 2025

Written by | 19 Sep 2025 | Conference Highlights

Phio Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology to eliminate cancer. Phio announced that Phio Pharmaceuticals is a presenting company at the Life Sciences Future Conference to be held September 25 – 26, 2025.

Mr. Robert Bitterman, President and CEO of Phio Pharmaceuticals, will deliver an update on its on-going Phase 1b clinical trial for skin cancer. He will also be discussing strategy and anticipated next steps in the PH-762 development program upon completion of the treatment phase of the study. Mr. Bitterman and his management team will also be available for one-on-one meetings throughout the conference September 25 – 26, 2025.

Presentation Details: September 26, 2025 at 10:00 AM EST
Location: Life Sciences Future Conference, Sheraton Valley Forge Hotel, King of Prussia, PA

Life Sciences Future is the annual meeting of the Pennsylvania life sciences community hosted by Life Sciences PA (formerly Pennsylvania Bio). Key stakeholders including pharmaceutical companies, research institutions, investment organizations and strategic advisors are invited to participate in the September meeting in King of Prussia, PA

Newsletter Icon

Register for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.